 Estradurin or Sintofolin. (Folia Morphol 2016; 74, 4: 467-473) 
INTRODUCTION
General and local modifications appear during menopause as a response to the deficiency in oestrogens, which may occur progressively in natural menopause, or suddenly in surgical menopause [11, 24] . Such morphological and structural modifications are often associated with alterations in various organs, thus influencing the quality of life [10, 23] .
Over the last years, there has been some controversy over hormone replacement therapy, due to its various side effects, such as breast, endometrial and ovarian cancer, cerebrovascular accident, or thromboembolic disease [7, 20, 25] . These risks can be avoided through correct monitoring, mammography and echography with measurement of endometrial thickness [3] .
A decrease in hormonal activity can be experimentally created through bilateral ovariectomy in female rats [17] . The ovariectomy in the rat induces permanent anoestrus, but it is not similar to the human physiological menopause. This experimental model plays an important role in understanding the pathophysiological modifications of the anoestrus syndrome, thus helping in the development of multiple adjuvant therapies [5, 12] .
It is known that the action of oestrogens is exerted through receptors in the genital tract, the mammary gland and the nervous system [26] .
Oestrogens have an important regulating effect on cell proliferation, a function that is mediated by the alpha (ER-a) and beta (ER-b) oestrogenic receptors [9] . Under normal conditions, ER-a receptors are expressed in the adenohypophysis, breast, uterus, uterine tract and vagina, while ER-b receptors are expressed in the urinary tract, ovary, thyroid, skin, lung and thymus [18, 33] . Due to the large number of oestrogenic receptors in the vagina and vulva, the latter will react promptly to the action of oestrogens, both natural and synthetic [1, 2, 8] .
This experimental study aims to assess the histological modifications occurring in the vagina and vulva of ovariectomised female rats, as well as the response to the administration of injectable oestrogens.
MaTeRIalS aND MeTHODS
This study was conducted using a total of 30 female Wistar white rats, with an average weight of 200 g, obtained from the laboratory animal facility of the "Iuliu Hatieganu" University of Medicine and Pharmacy of Cluj-Napoca. Throughout the experiment, the rats were given standard food and water ad libitum, thus observing the standard conditions required by the current legislation on the protection of laboratory animals.
The following study groups were created: -Group 1 -control group (no surgical intervention, no oestrogenic treatment, pre anoestrus), including 5 subjects; -Group 2 -operated, anoestrus, without treatment -5 subjects; -Group 3 -operated and treated with Estradiol (i.e. a natural oestrogen, at a dosage of 0.2 mg/day/rat, for a period of 14 days) -6 subjects; -Group 4 -operated and treated with Estradurin (i.e. a synthetic oestrogen, at a dosage of 0.2 mg/ /rat, every 7 days, for a period of 14 days) -7 subjects; -Group 5 -operated and treated with Sintofolin (i.e. a synthetic oestrogen, at a dosage of 0.2 mg/ /day/rat, for a period of 14 days) -7 subjects. Bilateral ovariectomy was performed in 25 of the 30 female rats included in the study. The ovariectomy was performed in accordance with the technique described by Nevalainen et al. [22] . The animals were anesthetized by intramuscular injection of a mixture of Xylasine (10 mg/kg, Xylocontact) and ketamine (100 mg/kg). The neuroleptanalgesia was induced for a period of 30-90 min, time needed for the surgical intervention. Under sterile conditions, a 2-3 cm ventral midline incision was made into the skin and muscle wall of the upper abdomen (to expose the ovaries). After permanent haemostasis, the ovaries were removed and the skin was closed with interrupted 3-0 silk sutures. The anoestrus phase was considered to be installed 15 days after surgery. To confirm this, the oestradiol level was tested 15 days after surgery, in order to compare oestradiol hormonal levels pre and post-surgery.
Once the anoestrus was confirmed in all study groups, we began administering various injectable oestrogen hormonal formulas, over a 14-day period.
Estradiol (Biofarm, Bucharest, Romania, Zip code: 031212) was used for group 3; each 1 mL-vial of injectable oily liquid contained 2.5 mg oestradiol, which was diluted in 9 mL neutralised and sterilised sunflower oil, so that for a dose 0.2 mg of oestradiol/ /rat/day, we administered 0.8 mL of oily solution. Estradurin (Pharmacia & Upjohn Company LLC [a subsidiary of Pfizer Inc.]), 7000 Portage Road Kalamazoo, MI 49001 United States, is a synthetic oestrogen which was used for group 4; each 2 mL-vial contained 80 mg of powdered polyoestradiol phosphate, diluted in 38 mL of distilled water, so that for 0.2 mg of oestradiol/ /rat/day, we administered 0.1 mL solution. Estradurin was administered at 7-day intervals since it is a powerful phosphatase inhibitor, with a particularly slow release, ensuring considerable oestrogenic activity for a prolonged period of time, even weeks after the injection. Sintofolin (Terapia S.A, 400632, ClujNapoca, jud. Cluj, Romania), a synthetic oestrogen, was used for group 5; each 2 mL vial of injectable oily liquid contained 5 mg of hexoestrol diacetate, which was diluted with 8 mL of neutralised and sterilised sunflower oil, so that 0.4 mL of oily solution was administered for 0.2 mg/rat/day.
For the histopathological examination, biopsies from the vaginal mucosa and vulva were placed in 10% neutral buffered formalin, included in paraffin, and 4 micrometre sections were cut with a Leica RM 2125 RT microtome. The sections were stained with the haematoxylin-eosin (HE) method. They were examined with an Olympus BX 51 microscope; the images were taken with an Olympus DP 25 digital camera, and then edited with the help of the Olympus Cell B application.
Statistical analysis
We first performed a descriptive analysis of the variables, at both the parametric (using means and standard deviations) and the graphic levels. Since all variables are quantitative (scales), we assessed the At the end of the study, 14 days after treatment, all the animals were sacrificed using the cervical dislocation method. Vaginal and vulvar biopsies were taken from all groups, and the samples were subjected to a histopathological examination, so as to obtain the necessary results and data for attaining the objective of this experimental study.
Vaginal and vulvar biopsies were taken from all groups and the samples were examined by a pathologist from the Department of Veterinary Toxicology of the University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca.
The protocol used in this experimental study was approved by the Ethics Committee of the "Iuliu Hatieganu" University of Medicine and Pharmacy of ClujNapoca (approval no. 116/06.03.2015). concluded that the type of treatment has a significant influence on the thickness of the vulva (Fig. 4) . Atrophy of the vulva and vagina was calculated using 3-point morphometric measurements; this method insured a real morphological quantification and found statistically significant differences between groups.
Furthermore, during the study, we assessed the structural changes of the vagina and vulva on the biopsy samples. Apart from the changes in the diameter of uterine horns found in the oestrogenic treatment groups, no macroscopic lesions were clearly noticeable during necropsy. The sections in the vaginal epithelium in group 1 (the control group) exhibited a normal morphology. The subjects in group 2 had a mild congestion of the submucosa, normality of their distribution, in order to establish the type of tests to be applied (parametric or nonparametric). The final decision was taken on the basis of the Shapiro-Wilk test.
The variation in corporal mass was studied on the sample of 25 operated rats. Since we measured the same individuals repeatedly, we performed the Repeated Measures type of multivariate analysis of variance (MANOVA).
We compared the pre-and post-surgery Estradiol values using the Paired Samples Student (t) test.
The comparison of the thickness of the vagina and vulva, among the five study groups, was performed using the ANOVA method (analysis of variance in a simple format). The standard level of significance considered was 5%, but when the results were significant at 1% level, this was clearly stated.
ReSUlTS
During the study, we recorded variations of the body mass of each subject, leading to statistically significant differences among the groups, such as an increase in weight in group 2 rats and a decrease in weight in groups 3, 4 and 5 ( Table 1, Fig. 1 ).
Surgically-induced anoestrus was demonstrated by determining post-surgery oestradiol levels, which were significantly different between the study groups (p = 0.000 < 0.01) (Fig. 2) .
There were statistically significant differences in thickness of the vaginal epithelium between the groups treated with injectable oestrogens, (p = 0.000 < 0.05), proving that the type of treatment has a significant influence on the thickness of the vagina (Fig. 3 ).
There were statistically significant differences in thickness of the vulva between the groups treated with injectable oestrogens (p = 0.000 < 0.05). We therefore 
DISCUSSIONS
The experimental model of hormone replacement therapy, associated with surgically-induced anoestrus through bilateral ovariectomy in female rats, is wellknown [16, 28, 31] . In accordance with the validated animal model, the histopathological analysis in group 2 found evident atrophy in the epithelium, chorion and glandular tissues of the vagina and vulva. This atrophy is associated with the absence of epithelial cornification, which are typical changes found in surgically-induced anoestrus in female rats. It is known that the cornification of the vaginal epithelium is a hormone-dependent phenomenon; some studies in literature report the presence of cornification in the absence of internal oestrogenic secretion in rats treated with oestrogens after birth [13, 15, 30] . In the groups treated with injectable oestrogens (Estradiol, Estradurin, Sintofolin), we found a marked presence of cell hyperplasia, along with a rich eosinophilic infiltration in the chorion and mast cell infiltration.
In this experimental study, Estradiol had the strongest effect on the proliferation of vaginal and vulvar epithelium, while Sintofolin had the weakest effect. Of the synthetic oestrogens, the Estradurin therapy yielded the strongest effect.
The response to injectable oestrogen treatment is fast and is due to the presence of a large number of oestrogenic receptors, either ER-a, or ER-b, in the genital and mammary system [19, 27] .
We found that all three types of oestrogens used treated vaginal and vulvar atrophy.
Our study proves that treatment with injectable oestrogens for 14 consecutive days triggers vaginal and vulvar hyperplasia, as well as the improvement of structural modifications exhibited in ovariectomised female rats, in keeping with the findings of Kangas et al. [14] or Basha et al. [4] .
The application in medical practice of our results is an argument for using oestrogenic substances in hormone replacement therapy [6, 21] .
The morphological modifications occurring during menopause, due to the typical oestrogen deficiency, benefit from a considerable number of treatments and therapies, which are, however, often controversial with regard to the benefits, risks and side effects [29, 32] .
CONClUSIONS
The vulvar and vaginal manifestations of the anoestrus phase are a direct response to the oestrogen deficiency. These changes are even more conspicuous when they occur suddenly, after a bilateral ovariectomy. Moreover, we have demonstrated that the Estradiol therapy induces the most evident histological modifications, compared to Estradurin or Sintofolin. Estradiol was proven to be the most effective in treating the alterations occurring during surgically-induced anoestrus, while of the synthetic oestrogens, Estradurin had the strongest effect.
All three types of oestrogens, administered via injection over a period of 14 days, led to the involution of atrophy by inducing vaginal and vulvar hyperplasia, as well as the improvement in structural modifications appearing in female rats as a consequence of surgery-induced anoestrus.
